Prevalence of chronic kidney disease in primary care patients. results of a prospective observational study in 12 regions of Russia


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. Chronic kidney disease (CKD) has become a pandemic in recent decades, being the fifth most common cause of death from noncommunicable diseases. CKD is a risk factor for the development of cardiovascular diseases and associated mortality, and the treatment of these diseases requires significant health care costs. Early diagnosis and promptly prescribed diet and treatment for CKD can prevent or slow the progression of the disease.Objective. Determination of the proportion of primary care patients with risk factors, signs and symptoms of CKD who are not be followed up by a nephrologist.Material and methods. A prospective non-interventional observational study "Early diagnosis of chronic kidney disease in primary health care facilities" ("CKD screening") in routine clinical practice was carried out in 12 regions of the Russian Federation. All patients who met the inclusion criteria and had at least one sign, symptom or risk factor for CKD who visited participating primary health care (PHC) physicians during the project period were screened for the purposes of this study. Primary care physicians assessed risk factors, signs and symptoms of possible CKD using a questionnaire developed by the study authors. Patients with suspected CKD were advised to see a nephrologist. Descriptive statistics methods were used. No comparative analysis has been carried out. Continuous variables are represented by the number of observations, mean (Mean) with standard deviation (SD) and standard error (SE), first (Q1), second (Median) and third (Q3) quartiles, range of values (Min; Max).Results. 13,968 patients visited the PHC physicians participating in the project; 1124 (8%) of them were referred to a nephrologist by the PHC physician. The diagnosis of CKD was confirmed in 95% of patients further examined by a nephrologist. Distribution by CKD stages: C1 - 2.4%, C2 - 11.6%, C3 - 71.9%, C4 - 10.8% and C5 - 2.9%. Among patients with CKD C3: 33.4% had CKD C3a and 30.7% had CKD C3b. Among patients with confirmed CKD: 59% had uncontrolled arterial hypertension (AH), 50% were over 65 years old, chronic heart failure was present in 44% of patients, diabetes - in 34%, abdominal obesity - in 32%. Other diseases were less important as a risk factor for the development of CKD. The low-protein diet was prescribed by the nephrologists in 84.6% of patients.Conclusion. The prevalence of CKD in the Russian Federation is similar to the global rates. Among patients with CKD, stage C3 disease with high risk of progression to end-stage CKD, as well as the risk of cardiovascular mortality and morbidity prevails. The study reaffirmed that uncontrolled hypertension, age over 65, chronic heart failure, diabetes and abdominal obesity are the most important risk factors for CKD, and patients with these conditions or diseases need mandatory CKD screening. The scoring system for assessing the risks of CKD proposed by the authors, along with the traditional assessment of glomerular filtration rate and albuminuria, seems to be a suitable tool for early detection of renal dysfunction; further research to study the specificity and sensitivity of the proposed method is planned.

Full Text

Restricted Access

About the authors

Ashot M. Essaian

Pavlov Universi

Email: essaian.ashot@gmail.com
Dr. Sci. (Med.), Professor, Head of the Department of Nephrology and Dialysis

Grigory P. Arutyunov

Pirogov Russian National Research Medical University

Email: arutyunov_gp@rsmu.ru
Corresponding Member of the RAS, Dr. Sci. (Med.), Professor, Head of the Department of Propedeutics of Internal Diseases, Faculty of Pediatrics

Oleg G. Melikhov

Institute for Clinical Research

Email: melikhov.oleg@gmail.com
Dr. Sci. (Med.), Director

References

  1. Jager K.J., Kovesdy C., Langham R., et al. A single number for advocacy and communication - worldwide more than 850 million individuals have kidney diseases. Nephrol. Dial. Transplant. 2019;34(11):1803-5. https://doi.org/10.1093/ndt/gfz174.
  2. NCD Risk Factor Collaboration. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016;387:1513-30.
  3. IDF Diabetes Atlas Ninth Edition 2019; International Diabetes Federation, 2019.
  4. NCD Risk Factor Collaboration Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet. 2017;389:37-55.
  5. Xie Yan et al. Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int. 2018;94(3):567-81.
  6. Кобалава Ж.Д., Виллевальде С.В., Боровкова Н.Ю. и др. Распространенность маркеров хронической болезни почек у пациентов с артериальной гипертонией: результаты эпидемиологического исследования ХРОНОГРАФ. Кардиология. 2017;57(10):39-44. https://doi.org/10.18087/cardio.2017.10.10041.
  7. Sarnak M.J., Levey A.S., Schoolwerth A.C., et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation. 2003;108:2154-69.
  8. Matsushita K., Coresh J., Sang Y., et al. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. Lancet. Diab. Endocrinol. 2015;3:514-25.
  9. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kid. Int. Suppl. 2013;3:1-150.
  10. Tuot D.S., Zhu Y., Velasquez A., et al. Variation in patients’ awareness of CKD according to how they are asked. Clin. J. Am. Soc. Nephrol. 2016;11:1566-73.
  11. https://www.usrds.org/adrhighlights.aspx 2017 Annual Data Report Highlights.
  12. Ощепкова Е.В., Долгушева Ю.А., Жернакова Ю.В. и др. Распространенность нарушения функции почек при артериальной гипертонии (по данным эпидемиологического исследования ЭССЕ-РФ). Системные гипертензии. 2015;12(3):19-24.
  13. Фадин Д.В., Федин В.А., Зингерман Б.В. и др. Результаты 5-летнего опыта тестирования лабораторией ИНВИТРО скорости клубочковой фильтрации на территории РФ. Клиническая нефрология. 2021;2;27-33.
  14. Ikizler T.A., Burrowes J.D., Byham-Gray L.D., et al; KDOQI Nutrition in CKD Guideline Work Group. KDOQI clinical practice guideline for nutrition in CKD: 2020 update. Am. J. Kidney Dis. 2020;76(3)(Suppl. 1):S1-107.
  15. Garneata L., Stancu A., Dragomir D., et al. Stefan G., and Mircescu G. Ketoanalogue-Supplemented Vegetarian Very Low-Protein Diet and CKD Progression. J. Am Soc Nephrol 2016;27:2164-2176.
  16. Национальные Клинические Рекомендации «Седечно-сосудистый риск и хроническая болезнь почек: стратегии кардионефропротекции». Российский кардиологический журнал. 2014;8(112):7-37.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies